News & Press Releases

New Scientific article on Artificial Intelligence in the context of OBERON
26 April 2021
> Dissemination > News & Press Releases > Publications

Identification of non-validated endocrine disrupting chemical characterization methods by screening of the literature using artificial intelligence and by database exploration A new article by Elias Zgheib – postdoc working on the project – has been published in Environment International on Identifiation of non-validated EDCs characterization methods by screening of the literature using AI and by database Read the full article…

OBERON Newsletter
March 2021
> Dissemination > News & Press Releases

OBERON first Newsletter OBERON March 2021 Newsletter, please subscribe by leaving us a message in the Contact Us section. March 2021 Newsletter

Mention of scientists from the Czech Institute of Biophysics participation in OBERON
5 October 2020
> Dissemination > Documents > News & Press Releases > Publications

Mention of scientists from the Czech Institute of Biophysics participation in OBERON A short description of OBERON and participation of the Institute of Biophysics CAS in the project has been published in the Czech popular science magazine Vesmír (2020; vol. 99, issue 10, p. 600), in Czech. This one-page summary provides a short description of Read the full article…

Possible connection between exposure to endocrine disruptors and COVID-19 severity
November 23, 2020
> News & Press Releases > Publications

NEW ARTICLES : New press articles have been posted on the link between ED’s exposure and COVID-19 severity Inserm press article “Rôle possible de l’exposition aux perturbateurs endocriniens dans la sévérité de la Covid-19” Pubmed article “New research examines suspected links between EDCs exposure and COVID-19” Inserm article (FR) Pubmed article (EN)

OBERON press release
14 April 2019
> News & Press Releases

Coordinated by Inserm, the European project OBERON aims to develop panels of tests that will – eventually – make it possible to determine with more accuracy and certitude how compounds suspected of being endocrine disruptors might induce metabolic disorders and, ultimately, to identify these compounds.

EURION Cluster Launch Event
1st January 2019
> News & Press Releases

Joint Launch Event of Projects from the Call ‘New Testing and Screening Methods to Identify Endocrine Disrupting Chemicals’ The current testing tools, including regulatory in vivo tests and novel in vitro assays, do not appropriately identify effects related to certain less studied endocrine-mediated pathways or health outcomes, in which endocrine disruptors may be implicated. The focus of proposals should Read the full article…

© OBERON 2019, Website Created by FMOSys